🇺🇸 FDA
Patent

US 9254310

Therapeutic and cosmetic uses and applications of calreticulin

granted A61KA61K2800/91A61K38/1738

Quick answer

US patent 9254310 (Therapeutic and cosmetic uses and applications of calreticulin) held by CALREGEN INC. expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CALREGEN INC.
Grant date
Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2800/91, A61K38/1738, A61K8/0208, A61K8/64